News &amp; Updates

A new coronavirus subvariant, “Arcturus,” has been making headlines in the US with the increased number of cases and no less than the US Centers for Disease Control and Prevention (CDC) has put it on its watch list.

What are the risk factors for relapse after methotrexate dose reduction?

For patients with rheumatoid arthritis, a history of cardiovascular disease, gastrointestinal disease, or liver disease, as well as prior use of nonsteroidal anti-inflammatory drugs can contribute to an increased risk of relapse after methotrexate dose reduction, as suggested in a study.

25 Apr 2023

Wirelessly powered e-stent: A promising, noninvasive GERD treatment

Researchers from the Chinese University of Hong Kong (CUHK) have developed a wireless, battery-free, deformable electronic stent (e-stent) for treatment of gastroesophageal reflux disease (GERD), eliminating the need for invasive surgery.

Novel ablation strategy superior to PVI for persistent AF

A three-step ablation strategy that systematically targets multiple proarrhythmogenic atrial structures appeared superior to pulmonary vein isolation (PVI) alone in patients with persistent atrial fibrillation (AF), according to 10-month results of a new study presented at EHRA 2023.

Statin use tied to lower stroke risk in patients with AF

Among patients with atrial fibrillation (AF), statin use was associated with a significantly lower risk of stroke or transient ischaemic attack (TIA) compared with non-use, according to a study presented at EHRA 2023.

Pregnancy a risk factor for COVID-19 among unvaccinated women

Pregnant women who remain unvaccinated from COVID-19 are at increased risk of contracting COVID-19 when compared with unvaccinated nonpregnant women, as reported in a study for the Philippines.

24 Apr 2023

Unhealthy eating blamed for rise in T2D cases worldwide

24 Apr 2023 by

Poor dietary choices have driven type 2 diabetes (T2D) up to a staggering 14.1 million cases in 2018, accounting for about 70 percent of all new T2D diagnoses around the world, according to a study.

Adverse events occur in two-thirds of NASH patients on placebo

Nearly two in three participants in the placebo arm of nonalcoholic steatohepatitis (NASH) randomized clinical trials (RCTs) experience an adverse event (AE), while one in 10 have a serious AE, according to a pooled analysis of studies with NASH placebo.

$Telecarers improve treatment, compliance in older hip fracture patients$

Telecarers improve treatment, compliance in older hip fracture patients

24 Apr 2023 by

Telecarers are beneficial in the monitoring of older hip fracture patients who are undergoing osteoporosis treatment, suggests a Singapore study. However, patient or family rejection and physician failure to prescribe persist as limitations of treatment.

24 Apr 2023

CPAP prevents atrial enlargementin MS patients with OSA

Treatment with continuous positive airway pressure (CPAP) for 6 months deters atrial remodeling and improves the possibility of achieving diastolic dysfunction reversibility in patients with metabolic syndrome (MS) and obstructive sleep apnoea (OSA), a study has shown.